James V. Cassella, EVP, R&D and CSO at Alexza Pharmaceuticals Inc. (ALXA), sold 4,558 shares at $4.90 ($22K) on 2012-12-26, disclosed to the SEC on 2012-12-27.
Scheduled sale ($22k) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |